Simplex Trading
VVOS icon

Simplex Trading’s Vivos Therapeutics VVOS Stock Holding History

Simplex Trading’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32
Closed -$1K – 10984
2022
Q2 		$1K Sell
32
-4
-11% -$166 ﹤0.01% 9697
2022
Q1 		$2K Sell
36
-484
-93% -$31.6K ﹤0.01% 9954
2021
Q4 		$29K Buy
+520
New +$41.9K ﹤0.01% 7960

Other funds holding VVOS

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Simplex Trading's VVOS Position: Q4 2023 in Review

Simplex Trading sold out of Vivos Therapeutics (VVOS) in Q4 2023, closing a stake of 7 shares.

Simplex Trading first reported a position in VVOS in Q1 2022 and held it in 5 quarters. The position peaked at $9K in Q1 2022. 18 funds tracked by Wall St. Rank hold VVOS as of Q4 2023.

  • Simplex Trading reported no remaining Vivos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Simplex Trading sold 7 Vivos Therapeutics shares in Q4 2023.
  • Simplex Trading first reported a position in Vivos Therapeutics in Q1 2022 and held it in 5 quarters.
  • Simplex Trading's Vivos Therapeutics position peaked at $9K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.